Alnylam Pharmaceuticals, INC. (ALNY) — DEFA14A Filings

All DEFA14A filings from Alnylam Pharmaceuticals, INC.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (3)

DEFA14A Filing — Apr 6, 2026
Alnylam Pharmaceuticals Files Proxy Statement Amendment — Apr 4, 2025 Risk: low
Alnylam Pharmaceuticals, Inc. filed an amendment (Amendment No. 1) to its Definitive Proxy Statement on April 4, 2025. This filing is related to the solicitatio
Alnylam Pharmaceuticals Files Proxy Materials — Mar 24, 2025 Risk: low
Alnylam Pharmaceuticals, Inc. filed a Definitive Additional Materials proxy statement on March 24, 2025. This filing is related to the company's proxy statement

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX